{"entity":{"type":"insider","cik":"0001402393","url":"/insider/0001402393","json_url":"/insider/0001402393.json","name":"Advent Partners HLS III Limited Partnership","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2010-10-27","last":"2012-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Advent Partners HLS III Limited Partnership","source":"filing","n_filings":7,"first_seen":"2010-10-27","last_seen":"2012-03-14"}],"transactions":[{"id":2861764,"accession":"0001209191-12-018183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-018183","line_url":"/filing/0001209191-12-018183#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1103.0,"shares_display":"1,103","price_per_share":15.8683,"price_display":"15.87","price_state":"stated","total_value":17502.7349,"total_display":"17,502.73","total_whole":"17,503","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-09","filed_date":"2012-03-14","scope":"insider"},{"id":2318146,"accession":"0001209191-12-006412","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-006412","line_url":"/filing/0001209191-12-006412#line-3","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":246.0,"shares_display":"246","price_per_share":17.1015,"price_display":"17.10","price_state":"stated","total_value":4206.969,"total_display":"4,206.97","total_whole":"4,207","shares_owned_after":28217.0,"shares_owned_after_display":"28,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-31","filed_date":"2012-01-31","scope":"insider"},{"id":2318131,"accession":"0001209191-12-006412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-006412","line_url":"/filing/0001209191-12-006412#line-2","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30.0,"shares_display":"30","price_per_share":17.0648,"price_display":"17.06","price_state":"stated","total_value":511.944,"total_display":"511.94","total_whole":"512","shares_owned_after":28463.0,"shares_owned_after_display":"28,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-30","filed_date":"2012-01-31","scope":"insider"},{"id":2318125,"accession":"0001209191-12-006412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-006412","line_url":"/filing/0001209191-12-006412#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":552.0,"shares_display":"552","price_per_share":17.1655,"price_display":"17.17","price_state":"stated","total_value":9475.356,"total_display":"9,475.36","total_whole":"9,475","shares_owned_after":28493.0,"shares_owned_after_display":"28,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-27","filed_date":"2012-01-31","scope":"insider"},{"id":9091859,"accession":"0001209191-11-060583","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-060583","line_url":"/filing/0001209191-11-060583#line-2","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196.0,"shares_display":"196","price_per_share":16.8906,"price_display":"16.89","price_state":"stated","total_value":3310.5576,"total_display":"3,310.56","total_whole":"3,311","shares_owned_after":29045.0,"shares_owned_after_display":"29,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-09","filed_date":"2011-12-09","scope":"insider"},{"id":9091858,"accession":"0001209191-11-060583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-060583","line_url":"/filing/0001209191-11-060583#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28.0,"shares_display":"28","price_per_share":16.8952,"price_display":"16.90","price_state":"stated","total_value":473.0656,"total_display":"473.07","total_whole":"473","shares_owned_after":29241.0,"shares_owned_after_display":"29,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-08","filed_date":"2011-12-09","scope":"insider"},{"id":9182954,"accession":"0001209191-11-060331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-060331","line_url":"/filing/0001209191-11-060331#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61.0,"shares_display":"61","price_per_share":16.958,"price_display":"16.96","price_state":"stated","total_value":1034.438,"total_display":"1,034.44","total_whole":"1,034","shares_owned_after":29269.0,"shares_owned_after_display":"29,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-06","filed_date":"2011-12-08","scope":"insider"},{"id":8834165,"accession":"0001209191-11-041607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-041607","line_url":"/filing/0001209191-11-041607#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57.0,"shares_display":"57","price_per_share":14.6087,"price_display":"14.61","price_state":"stated","total_value":832.6959,"total_display":"832.70","total_whole":"833","shares_owned_after":29330.0,"shares_owned_after_display":"29,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-29","filed_date":"2011-07-29","scope":"insider"},{"id":9064180,"accession":"0001209191-11-036763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-036763","line_url":"/filing/0001209191-11-036763#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1349.0,"shares_display":"1,349","price_per_share":14.6087,"price_display":"14.61","price_state":"stated","total_value":19707.1363,"total_display":"19,707.14","total_whole":"19,707","shares_owned_after":29387.0,"shares_owned_after_display":"29,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-29","filed_date":"2011-06-29","scope":"insider"},{"id":7707508,"accession":"0001209191-10-051880","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-051880","line_url":"/filing/0001209191-10-051880#line-4","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001402393","owner_name":"Advent Partners HLS III Limited Partnership","owner_display_name":"Advent Partners HLS III Limited Partnership","owner_url":"/insider/0001402393","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2895.0,"shares_display":"2,895","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":27502.5,"total_display":"27,502.50","total_whole":"27,503","shares_owned_after":30736.0,"shares_owned_after_display":"30,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Other","n_filings":7,"first_seen":"2010-10-27","last_seen":"2012-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001402393","retrieved_at":"2026-08-24T05:17:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}